TITLE

Managing Parkinson's disease

AUTHOR(S)
Robinson, Gina
PUB. DATE
February 2010
SOURCE
Independent Nurse;2/15/2010, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses Parkinson's disease, which is a degenerative neurological disease that affects 120,000 individuals in Great Britain aged 55-60 years old. Unilateral resting tremors, slowness and poor balance are among the symptoms of Parkinson's disease and its diagnosis is usually based on the brain bank criteria of Great Britain. Patients commonly suffers constipation due to reduced gut motility and medication, while others needed to be referred to a urologist due to urinary frequency at light that cause lethargy to some patients.
ACCESSION #
48990294

 

Related Articles

  • Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms. Lebouvier, Thibaud; Neunlist, Michel; des Varannes, Stanislas Bruley; Coron, Emmanuel; Drouard, Anne; N'Guyen, Jean-Michel; Chaumette, Tanguy; Tasselli, Maddalena; Paillusson, Sébastien; Flamand, Mathurin; Galmiche, Jean-Paul; Damier, Philippe; Derkinderen, Pascal // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Background: The presence of Lewy bodies and Lewy neurites (LN) has been demonstrated in the enteric nervous system (ENS) of Parkinson's disease (PD) patients. The aims of the present research were to use routine colonoscopy biopsies (1) to analyze, in depth, enteric pathology throughout the...

  • Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Annie Lannuzel; G. U. Höglinger; S. Verhaeghe; L. Gire; S. Belson; M. Escobar-Khondiker; P. Poullain; W. H. Oertel; E. C. Hirsch; B. Dubois; M. Ruberg // Brain: A Journal of Neurology;Mar2007, Vol. 130 Issue 3, p816 

    In Guadeloupe, there is an abnormally high frequency of atypical parkinsonism. Only one-third of the patients that develop parkinsonian symptoms were reported to present the classical features of idiopathic Parkinson disease and one-third a syndrome resembling progressive supranuclear palsy...

  • The L-dopa response in vascular parkinsonism. Zijlmans J C M; Katzenschlager R; Daniel S E; Lees A J L; Zijlmans, J C M; Katzenschlager, R; Daniel, S E; Lees, A J L // Journal of Neurology, Neurosurgery & Psychiatry;Apr2004, Vol. 75 Issue 4, p545 

    Objective: To determine whether a positive L-dopa response in vascular parkinsonism (VP) is correlated with the presence of nigrostriatal pathology due to either vascular damage or neuronal cell loss.Methods: Seventeen patients with pathologically confirmed VP were...

  • Timing the initiation of treatment in Parkinson's disease. Grosset, Donald G.; Schapira, Anthony H. // Journal of Neurology, Neurosurgery & Psychiatry;Jun2008, Vol. 79 Issue 6, p615 

    The article presents views and insights of the author concerning the timing in the initiation of treatment in Parkinson's disease (PD). Clinical, imaging and pathological studies suggest that the cell loss begins 7 to 10 years before the onset of clinical features sufficient to allow the...

  • The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease. D Aarsland // Journal of Neurology, Neurosurgery & Psychiatry;Aug2009, Vol. 80 Issue 8, p928 

    BACKGROUND: Neuropsychiatric symptoms are common in Parkinson’s disease (PD) and have important clinical consequences for patients, caregivers and society. Few studies of neuropsychiatric symptoms in early untreated PD exist. OBJECTIVE: To explore the range, clustering and correlates of...

  • Spatial distribution of Parkinson's disease mortality in Spain, 1989-1998, as a guide for focused aetiological research or health-care intervention. de Pedro-Cuesta, Jesús; Rodríguez-Farré, Eduard; Lopez-Abente, Gonzalo // BMC Public Health;2009, Vol. 9 Issue 1, p445 

    Background: Aetiologically, genetic and environmental factors having an uneven spatial distribution may underlie Parkinson's disease (PD). Undiagnosis of PD in selected regions might have limited access to treatment with levodopa and simultaneously, if present at death, determined PD...

  • Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease.  // Neurochemical Research;Mar2008, Vol. 33 Issue 3, p589 

    Abstract  Environmental toxins, genetic predisposition and old age are major risk factors for Parkinson’s disease (PD). Although the mechanism(s) underlying selective dopaminergic (DA) neurodegeneration remain unclear, molecular studies in both toxin based models and...

  • An Experience of Health Technology Assessment in New Models of Care for Subjects with Parkinson’s Disease by Means of a New Wearable Device. Daniele Giansanti; Giovanni Maccioni; Sandra Morelli // Telemedicine & e-Health;Jun2008, Vol. 14 Issue 5, p467 

    This report characterizes a system combining gastrocnemius expansion measurement unit (GEMU), a step-counting device, with a telemedicine application for patients with Parkinsonism. GEMU by telemedicine correlated strongly with motion decrement in a robust and reliable system, which enjoyed high...

  • Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London. Schrag, A.; Ben-Shlomo, Y.; Quinn, N.P. // BMJ: British Medical Journal (International Edition);07/01/2000, Vol. 321 Issue 7252, p21 

    Reports the prevalence of idiopathic Parkinson's disease and other parkinsonian syndromes in 1997 in the London, England area. Subjects, methods, and results; Suggestion of no marked geographical variation.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics